Cargando…
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496665/ https://www.ncbi.nlm.nih.gov/pubmed/33760951 http://dx.doi.org/10.1007/s00277-021-04503-1 |
_version_ | 1784579801417252864 |
---|---|
author | Swoboda, Ryszard Giebel, Sebastian Knopińska-Posłuszny, Wanda Chmielowska, Ewa Drozd-Sokołowska, Joanna Paszkiewicz-Kozik, Ewa Kulikowski, Waldemar Taszner, Michał Mendrek, Włodzimierz Najda, Jacek Czerw, Tomasz Olszewska-Szopa, Magdalena Czyż, Anna Giza, Agnieszka Spychałowicz, Wojciech Subocz, Edyta Szwedyk, Paweł Krzywon, Aleksandra Wilk, Agata Zaucha, Jan Maciej |
author_facet | Swoboda, Ryszard Giebel, Sebastian Knopińska-Posłuszny, Wanda Chmielowska, Ewa Drozd-Sokołowska, Joanna Paszkiewicz-Kozik, Ewa Kulikowski, Waldemar Taszner, Michał Mendrek, Włodzimierz Najda, Jacek Czerw, Tomasz Olszewska-Szopa, Magdalena Czyż, Anna Giza, Agnieszka Spychałowicz, Wojciech Subocz, Edyta Szwedyk, Paweł Krzywon, Aleksandra Wilk, Agata Zaucha, Jan Maciej |
author_sort | Swoboda, Ryszard |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8496665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84966652021-10-29 Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma Swoboda, Ryszard Giebel, Sebastian Knopińska-Posłuszny, Wanda Chmielowska, Ewa Drozd-Sokołowska, Joanna Paszkiewicz-Kozik, Ewa Kulikowski, Waldemar Taszner, Michał Mendrek, Włodzimierz Najda, Jacek Czerw, Tomasz Olszewska-Szopa, Magdalena Czyż, Anna Giza, Agnieszka Spychałowicz, Wojciech Subocz, Edyta Szwedyk, Paweł Krzywon, Aleksandra Wilk, Agata Zaucha, Jan Maciej Ann Hematol Correction Springer Berlin Heidelberg 2021-03-24 2021 /pmc/articles/PMC8496665/ /pubmed/33760951 http://dx.doi.org/10.1007/s00277-021-04503-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Swoboda, Ryszard Giebel, Sebastian Knopińska-Posłuszny, Wanda Chmielowska, Ewa Drozd-Sokołowska, Joanna Paszkiewicz-Kozik, Ewa Kulikowski, Waldemar Taszner, Michał Mendrek, Włodzimierz Najda, Jacek Czerw, Tomasz Olszewska-Szopa, Magdalena Czyż, Anna Giza, Agnieszka Spychałowicz, Wojciech Subocz, Edyta Szwedyk, Paweł Krzywon, Aleksandra Wilk, Agata Zaucha, Jan Maciej Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma |
title | Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma |
title_full | Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma |
title_fullStr | Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma |
title_full_unstemmed | Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma |
title_short | Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma |
title_sort | correction to: high efficacy of bgd (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory hodgkin lymphoma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496665/ https://www.ncbi.nlm.nih.gov/pubmed/33760951 http://dx.doi.org/10.1007/s00277-021-04503-1 |
work_keys_str_mv | AT swobodaryszard correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT giebelsebastian correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT knopinskaposłusznywanda correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT chmielowskaewa correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT drozdsokołowskajoanna correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT paszkiewiczkozikewa correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT kulikowskiwaldemar correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT tasznermichał correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT mendrekwłodzimierz correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT najdajacek correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT czerwtomasz correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT olszewskaszopamagdalena correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT czyzanna correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT gizaagnieszka correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT spychałowiczwojciech correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT suboczedyta correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT szwedykpaweł correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT krzywonaleksandra correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT wilkagata correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma AT zauchajanmaciej correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma |